Clarinex
Product Images NDC 21695-815

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarinex (NDC 21695-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 01)

FDA Label Image

Shering Logo (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 02)

Shering Logo (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 02)
This is a contact information of Schering Corporation located in Kenilworth, NJ.*
FDA Label Image

Clarinex 5mg (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 03)

Clarinex 5mg (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 03)
Clarinex 5mg tablets, containing Desloratadine as the active ingredient, are a type of antihistamine used to treat allergic symptoms. Each package contains 10 round light blue film-coated tablets, embossed with "C5" and labeled as product ID PC081510. This medication is available only with a prescription and is manufactured by Cima Labs Inc. in Eden Prairie, MN, USA, but is of Irish origin. It is distributed by Physician Partner in Thousand Oaks, CA, USA, and should be stored at controlled room temperature between 15- 30°C. Caution should be taken to keep this medication out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.